-
R.
Rose,
R.
Reichman,
W.
Bonnez
(1994)
Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera.
The Journal of general virology, 75 ( Pt 8)
-
R.
Viscidi,
M.
Schiffman,
A.
Hildesheim,
R.
Herrero,
P.
Castle,
M.
Bratti,
A.
Rodriguez,
M.
Sherman,
Sophia
Wang,
B.
Clayman,
R.
Burk
(2004)
Short Communication Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica
-
A.
Touzé,
S.
Mehdaoui,
P.
Sizaret,
C.
Mougin,
N.
Muñoz,
P.
Coursaget
(1998)
The L1 Major Capsid Protein of Human Papillomavirus Type 16 Variants Affects Yield of Virus-Like Particles Produced in an Insect Cell Expression System
Journal of Clinical Microbiology, 36
-
K.
Kondo,
Y.
Ishii,
H.
Ochi,
Tamae
Matsumoto,
H.
Yoshikawa,
T.
Kanda
(2007)
Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Virology, 358 2
-
(2003)
Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students
-
D.
Pastrana,
R.
Gambhira,
C.
Buck,
Y.
Pang,
C.
Thompson,
Timothy
Culp,
N.
Christensen,
D.
Lowy,
J.
Schiller,
R.
Roden
(2005)
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.
Virology, 337 2
-
A.
Touzé,
S.
Sanjosé,
P.
Coursaget,
M.
Almirall,
V.
Palacio,
C.
Meijer,
J.
Kornegay,
F.
Bosch
(2001)
Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes
Journal of Clinical Microbiology, 39
-
G.
Ho,
Yevgeniy
Studentsov,
Charles
Hall,
R.
Bierman,
L.
Beardsley,
Michele
Lempa,
R.
Burk
(2002)
Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.
The Journal of infectious diseases, 186 6
-
T.
Gruijl,
H.
Bontkes,
J.
Walboomers,
P.
Coursaget,
M.
Stukart,
C.
Dupuy,
E.
Kueter,
René,
H.
Verheijen,
T.
Helmerhorst,
M.
Duggan-Keen,
P.
Stern,
C.
Meijer,
R.
Scheper
(1999)
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
The Journal of general virology, 80 ( Pt 2)
-
A.
Touzé,
Pierre
Coursaget
(1998)
In vitro gene transfer using human papillomavirus-like particles.
Nucleic acids research, 26 5
-
N.
Christensen,
J.
Kreider,
K.
Shah,
R.
Rando
(1992)
Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions.
The Journal of general virology, 73 ( Pt 5)
-
C.
Buck,
D.
Pastrana,
D.
Lowy,
J.
Schiller
(2005)
Generation of HPV pseudovirions using transfection and their use in neutralization assays.
Methods in molecular medicine, 119
-
M.
Fleury,
A.
Touzé,
E.
Alvarez,
G.
Carpentier,
C.
Clavel,
J.
Vautherot,
P.
Coursaget
(2006)
Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31
Archives of Virology, 151
-
G.
Ho,
Yevgeniy
Studentsov,
R.
Bierman,
R.
Burk
(2004)
Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women
Cancer Epidemiology Biomarkers & Prevention, 13
-
Y.
Stauffer,
K.
Raj,
K.
Masternak,
P.
Beard
(1998)
Infectious human papillomavirus type 18 pseudovirions.
Journal of molecular biology, 283 3
-
L.
Bousarghin,
Alba-Lucia
Combita-Rojas,
A.
Touzé,
S.
Mehdaoui,
P.
Sizaret,
M.
Bravo,
P.
Coursaget
(2002)
Detection of Neutralizing Antibodies against Human Papillomaviruses (HPV) by Inhibition of Gene Transfer Mediated by HPV Pseudovirions
Journal of Clinical Microbiology, 40
-
F.
Unckell,
R.
Streeck,
M.
Sapp
(1997)
Generation and neutralization of pseudovirions of human papillomavirus type 33
Journal of Virology, 71
-
R.
Gambhira,
Balasubramanyam
Karanam,
Subhashini
Jagu,
Jeffrey
Roberts,
C.
Buck,
I.
Bossis,
H.
Alphs,
Timothy
Culp,
N.
Christensen,
R.
Roden
(2007)
A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2
Journal of Virology, 81
-
V.
Geijersstam,
M.
Kibur,
Z.
Wang,
P.
Koskela,
E.
Pukkala,
J.
Schiller,
M.
Lehtinen,
J.
Dillner
(1998)
Stability over time of serum antibody levels to human papillomavirus type 16.
The Journal of infectious diseases, 177 6
-
Timothy
Culp,
Christin
Spatz,
C.
Reed,
N.
Christensen
(2007)
Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.
Virology, 361 2
-
R.
Roden,
E.
Weissinger,
Darren
Henderson,
F.
Booy,
R.
Kirnbauer,
R.
Kirnbauer,
J.
Mushinski,
D.
Lowy,
J.
Schiller
(1994)
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins
Journal of Virology, 68
-
Sophia
Wang,
M.
Schiffman,
R.
Herrero,
J.
Carreon,
A.
Hildesheim,
A.
Rodriguez,
M.
Bratti,
M.
Sherman,
J.
Morales,
Diego
Guillén,
M.
Alfaro,
B.
Clayman,
R.
Burk,
R.
Viscidi
(2004)
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
British Journal of Cancer, 91
-
Joseph
Carter,
L.
Koutsky,
G.
Wipf,
N.
Christensen,
Shu‐Kuang
Lee,
J.
Kuypers,
N.
Kiviat,
D.
Galloway
(1996)
The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.
The Journal of infectious diseases, 174 5
-
D.
Pastrana,
C.
Buck,
Y.
Pang,
C.
Thompson,
P.
Castle,
P.
FitzGerald,
S.
Kjaer,
D.
Lowy,
J.
Schiller
(2004)
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
Virology, 321 2